skip to main content

Eczema Action Plan — SCE Dermatology MCQ

Instant feedback + full explanation. One question, done properly.

HardInflammatory DermatosesEczema Action PlanSCE Dermatology

A patient whose atopic dermatitis is otherwise controlled on dupilumab develops persistent new facial and neck dermatitis. Which investigation is most useful before abandoning effective systemic treatment?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: B — Patch testing including the patient’s facial products

Dupilumab-associated head-and-neck dermatitis has several possible explanations, including unmasked allergic contact dermatitis, topical-product allergy, rosacea or Malassezia-associated inflammation. Patch testing with relevant extended series and personal products can identify a remediable cause.

Reference: https://www.nice.org.uk/guidance/cg57/chapter/recommendations